SPP1 and Fuchs endothelial corneal dystrophy: We propose that <i>SPP1</i> is a potential biomarker and therapeutic target for FECD, and the <i>NEAT1</i>/miR-181b-5p/<i>SPP1</i> axis might be a regulatory RNA pathway involved in FECD development.